Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells.
about
Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell linesCXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progressionCrosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasionThe inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancerLASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex.Short tail with skin lesion phenotype occurs in transgenic mice with keratin-14 promoter-directed expression of mutant CXCR2.Phosphorylation of chemoattractant receptors regulates chemotaxis, actin reorganization and signal relay.CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathwaysAdenosine arrests breast cancer cell motility by A3 receptor stimulation.[18F]tetrafluoroborate-PET/CT enables sensitive tumor and metastasis in vivo imaging in a sodium iodide symporter-expressing tumor modelAn essential role of the cytoplasmic tail of CXCR4 in G-protein signaling and organogenesis.Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targetsCytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.Characterization of chemokine receptor CXCR2 interacting proteins using a proteomics approach to define the CXCR2 "chemosynapse".Chemokine receptor Cxcr4 contributes to kidney fibrosis via multiple effectors.Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptorsChemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells.G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis.NMR metabolomics of MTLn3E breast cancer cells identifies a role for CXCR4 in lipid and choline regulation.Regulation of CXCR4 signaling.Constitutive CXCL12 expression induces anoikis in colorectal carcinoma cellsOSU-A9, a potent indole-3-carbinol derivative, suppresses breast tumor growth by targeting the Akt-NF-kappaB pathway and stress response signalingThe role of chemokines and their receptors in angiogenesis.Effects of ulinastatin and cyclophosphamide on the growth of xenograft breast cancer and expression of CXC chemokine receptor 4 and matrix metalloproteinase-9 in cancers.Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells.Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients.Interfering with CXCR4 expression inhibits proliferation, adhesion and migration of breast cancer MDA-MB-231 cells.
P2860
Q24323314-7D1C862F-042A-4A7A-8F83-3C40C7DA238BQ24635943-A6F793C8-F913-42DC-A761-4A0025DB22D3Q28476823-3E20F052-2A46-420D-B4A2-D5A4B5FB56CFQ28540458-0B0DC212-8AC2-4D9C-925D-38CE62F04C87Q30009171-26B75635-3A5D-402F-AA09-D5F1C3E48F4CQ30439068-6BD32BD1-387C-45E5-AD60-2070AF7BE2A6Q30550026-F830BAB8-C9C2-43DE-A95A-2119AFF5862CQ30572945-AEAFF056-424E-4711-89F8-742532B222BFQ30829844-4D372226-E5ED-44BA-90AE-3C9C4D68C8EBQ33680923-9A2CED9D-486D-4CC1-BDB8-70A744964573Q33761154-3D4F55C4-364B-40A5-9052-B40B79A6E0E1Q34023663-0F886B22-D9E2-4536-AB6E-767A5CD6DA58Q35118166-689DBBEB-9EB7-43D4-967F-9327EEB9D558Q35118194-6080C4CD-7132-471B-9642-C31FB6013B74Q35138504-520AC5CD-7C1A-409F-A631-CA8ED65150A2Q35140322-5E060F38-1EEF-4A0A-85AA-209C4E9BBFC3Q35573448-7969B381-B18B-452F-8C44-92EFF7FEE035Q35980816-9F531BAF-56D7-4DB3-BEBF-D0D16CB0CBCFQ36043738-A5688234-9863-4411-8DB8-9CEB3FDF1245Q36684219-9C3B71F8-AECF-4B98-B571-21420CC6CA5EQ36973786-71666B78-08D2-46C6-A912-930E8F996A4AQ37376593-653D9455-A34B-4236-A21B-74EA9D7C8394Q37863514-212E0594-3109-4DC3-BF56-9D2FD9EE82FCQ39659055-EE5C47A1-52F4-44CD-A142-E00B140A572AQ40088678-EEDD9647-6EAF-4BC6-B209-9FFD154115A0Q40621763-F4EA791B-B2C9-4034-BB7F-E49CAB37A606Q42124753-90A52EE6-E659-45F9-95C4-AF2CE2FF69CC
P2860
Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Deletion of the COOH-terminal ...... ion in breast carcinoma cells.
@en
Deletion of the COOH-terminal ...... ion in breast carcinoma cells.
@nl
type
label
Deletion of the COOH-terminal ...... ion in breast carcinoma cells.
@en
Deletion of the COOH-terminal ...... ion in breast carcinoma cells.
@nl
prefLabel
Deletion of the COOH-terminal ...... ion in breast carcinoma cells.
@en
Deletion of the COOH-terminal ...... ion in breast carcinoma cells.
@nl
P2093
P2860
P1433
P1476
Deletion of the COOH-terminal ...... ion in breast carcinoma cells.
@en
P2093
Ann Richmond
Dayanidhi Raman
Evemie Schutyser
Nicole F Neel
Yukiko Ueda
P2860
P304
P356
10.1158/0008-5472.CAN-05-3579
P407
P577
2006-06-01T00:00:00Z